glp-1 and exercise Strength Protocol Optimizing GLP-1 therapies for obesity

All authors read and agreed to the published version of the manuscript

Its resistance to gastric degradation relative to other peptides of similar length has been studied in rodent models

December 15, 2025: Study About the Brain Benefits of Taking Trulicity Shows Modest Connection, Inconclusive Results An observational study explored whether taking Trulicity and other GLP-1s was associated with some brain benefits, like lower risks of epilepsy

Contrave, which has been around for 10 years, is a combination of the antidepressant bupropion and naltrexone, an opioid antagonist designed to combat cravings

doi:10.1016/j.rbmo.2020.08.013